Retatrutide – 20 MG

Retatrutide – 20MG is a triple-receptor agonist peptide targeting the GLP-1, GIP, and glucagon receptors, offering a powerful tool for researchers studying obesity, type 2 diabetes, insulin resistance, and bodyweight regulation.

Positioned between the 10MG and 50MG options, the 20MG format is ideal for medium-length protocols or trials requiring repeated dosing across several phases.

Key Research Benefits:

• Triple Action Mechanism: Combines the benefits of GLP-1 (appetite control), GIP (insulin sensitivity), and glucagon (fat oxidation).

• Impressive Weight Loss Potential: Clinical studies report up to 24% body weight reduction, making it one of the most promising GLP analogues to date.

• Improved Insulin Sensitivity: Enhances glucose regulation in insulin-resistant models.

• Energy & Fat Metabolism: Promotes thermogenesis and lean mass preservation during caloric restriction.

Reconstitution & Storage:

• Reconstitute with 1–2ml of Bacteriostatic Water for Injection (BWFI).

• Gently swirl to dissolve. Do not shake.

• Store reconstituted solution in a refrigerator (2–8°C).

• Use within 30 days post-reconstitution.

Why Choose the 20MG Vial?

• Ideal balance of volume and flexibility for 2–3 week research windows

• High-purity, lab-tested batch with full COA (Certificate of Analysis)

• Suitable for both beginner and advanced research applications

• Compatible with blended GLP-1 protocols or mono-compound research

⚠️ Disclaimer: This product is sold for laboratory research only. It is not intended for human consumption, medical use, or therapeutic application.